SVB Leerink Reiterates Market Perform Rating on Gilead Sciences (GILD) Following Open Letter From CEO

March 30, 2020 8:46 AM EDT Send to a Friend
SVB Leerink analyst Geoffrey Porges reiterated a Market Perform rating and $68.00 price target on Gilead Sciences (NASDAQ: GILD) following ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login